Life Sciences
Life sciences is a broad, foundational field focused on the study of living organisms, encompassing disciplines such as biology and genetics. With rapid advancements, strong intellectual property protection is critical to safeguard these innovations.
Our Expertise
Experts in Life Science IP
MBIP has deep experience advising clients across the life sciences industries. With our team having worked at renowned research institutions, we understand both the technical and commercial elements of the life sciences, and the patent protection strategies needed to address the industry’s unique challenges.
How We Can Help
MBIP works closely with universities, life science innovators and organisations to develop IP strategies that reflect both scientific complexity and regulatory realities. Our approach is practical and commercially-focused, designed to support development pipelines, investment readiness and timely market entry in Australia and internationally. MBIP also proactively researches early market entry opportunities for our clients in the pharmaceutical market.
We can assist with:
- Patent drafting and prosecution
- Freedom-to-operate considerations
- Portfolio management for pharmaceutical and biotech innovations
- We also advise on eligibility and strategy for pharmaceutical patent term extensions
Australian Pharma and Life Sciences Decisions
Life Sciences:
Pharmaceuticals:
- Federal Court decisions and Patent Office decisions
- High Court decisions
2024 Patent Cases: Key Australian Decisions in Life Sciences and Pharmaceuticals
A comprehensive look at Australian Patent Decisions from 2024, specifically relating to the Pharmaceutical and Life Sciences spaces. In this booklet, Vanessa Yeung (Associate) has identified key takeaways and lessons for applicants and attorneys relating to decisions handed down by the Australia Patent Office, Australian Full Federal Court and the Australian High Court.
